Literature DB >> 24936068

B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cells.

Wells S Brown1, Jahan S Khalili2, Tania G Rodriguez-Cruz2, Greg Lizee2, Bradley W McIntyre3.   

Abstract

The regulation of integrin-mediated adhesion is of vital importance to adaptive and innate immunity. Integrins are versatile proteins and mediate T cell migration and trafficking by binding to extracellular matrix or other cells as well as initiating intracellular signaling cascades promoting survival or activation. The MAPK pathway is known to be downstream from integrins and to regulate survival, differentiation, and motility. However, secondary roles for canonical MAPK pathway members are being discovered. We show that chemical inhibition of RAF by sorafenib or shRNA-mediated knockdown of B-Raf reduces T cell resistance to shear stress to α4β1 integrin ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronectin, whereas inhibition of MEK/ERK by U0126 had no effect. Microscopy showed that RAF inhibition leads to significant inhibition of T cell spreading on VCAM-1. The association of α4β1 integrin with the actin cytoskeleton was shown to be dependent on B-Raf activity or expression, whereas α4β1 integrin affinity for soluble VCAM-1 was not. These effects were shown to be specific for α4β1 integrin and not other integrins, such as α5β1 or LFA-1, or a variety of membrane proteins. We demonstrate a novel role for B-Raf in the selective regulation of α4β1 integrin-mediated adhesion.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Anticancer Drug; Cell Adhesion; Cytoskeleton; Extracellular Signal-regulated Kinase (ERK); Fibronectin; Integrins; Raf Kinase; Shear Stress; T-cell

Mesh:

Substances:

Year:  2014        PMID: 24936068      PMCID: PMC4132812          DOI: 10.1074/jbc.M114.562918

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.

Authors:  Seunghee Yoon; Rony Seger
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

2.  TCR ligand avidity determines the mode of B-Raf/Raf-1/ERK activation leading to the activation of human CD4+ T cell clone.

Authors:  Hirotake Tsukamoto; Atsushi Irie; Yu-Zhen Chen; Kumiko Takeshita; Jeong-Ran Kim; Yasuharu Nishimura
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

3.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

4.  Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function.

Authors:  Andrea Boni; Alexandria P Cogdill; Ping Dang; Durga Udayakumar; Ching-Ni Jenny Njauw; Callum M Sloss; Cristina R Ferrone; Keith T Flaherty; Donald P Lawrence; David E Fisher; Hensin Tsao; Jennifer A Wargo
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

5.  Ras-induced serine phosphorylation of the focal adhesion protein paxillin is mediated by the Raf-->MEK-->ERK pathway.

Authors:  Melissa A Woodrow; Douglas Woods; Holly M Cherwinski; David Stokoe; Martin McMahon
Journal:  Exp Cell Res       Date:  2003-07-15       Impact factor: 3.905

6.  Phosphorylation of paxillin tyrosines 31 and 118 controls polarization and motility of lymphoid cells and is PMA-sensitive.

Authors:  Larisa Y Romanova; Shigeru Hashimoto; Kee-Oh Chay; Mikhail V Blagosklonny; Hisataka Sabe; J Frederic Mushinski
Journal:  J Cell Sci       Date:  2004-07-13       Impact factor: 5.285

7.  B-Raf-mediated signaling pathway regulates T cell development.

Authors:  Hirotake Tsukamoto; Atsushi Irie; Satoru Senju; Antonis K Hatzopoulos; Leszek Wojnowski; Yasuharu Nishimura
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

8.  A MEK-independent role for CRAF in mitosis and tumor progression.

Authors:  Ainhoa Mielgo; Laetitia Seguin; Miller Huang; Maria Fernanda Camargo; Sudarshan Anand; Aleksandra Franovic; Sara M Weis; Sunil J Advani; Eric A Murphy; David A Cheresh
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

9.  Alpha4beta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the alpha4-cytoplasmic domain.

Authors:  Ronen Alon; Sara W Feigelson; Eugenia Manevich; David M Rose; Julia Schmitz; Darryl R Overby; Eitan Winter; Valentin Grabovsky; Vera Shinder; Benjamin D Matthews; Maya Sokolovsky-Eisenberg; Donald E Ingber; Martin Benoit; Mark H Ginsberg
Journal:  J Cell Biol       Date:  2005-12-19       Impact factor: 10.539

10.  BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.

Authors:  Scott M Wilhelm; Christopher Carter; Liya Tang; Dean Wilkie; Angela McNabola; Hong Rong; Charles Chen; Xiaomei Zhang; Patrick Vincent; Mark McHugh; Yichen Cao; Jaleel Shujath; Susan Gawlak; Deepa Eveleigh; Bruce Rowley; Li Liu; Lila Adnane; Mark Lynch; Daniel Auclair; Ian Taylor; Rich Gedrich; Andrei Voznesensky; Bernd Riedl; Leonard E Post; Gideon Bollag; Pamela A Trail
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 13.312

View more
  6 in total

1.  Dehydro-β-proline Containing α4β1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay.

Authors:  Alessandra Tolomelli; Monica Baiula; Angelo Viola; Lucia Ferrazzano; Luca Gentilucci; Samantha Deianira Dattoli; Santi Spampinato; Eusebio Juaristi; Margarita Escudero
Journal:  ACS Med Chem Lett       Date:  2015-05-05       Impact factor: 4.345

2.  Activation of integrin α5 mediated by flow requires its translocation to membrane lipid rafts in vascular endothelial cells.

Authors:  Xiaoli Sun; Yi Fu; Mingxia Gu; Lu Zhang; Dan Li; Hongliang Li; Shu Chien; John Y-J Shyy; Yi Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-05       Impact factor: 11.205

3.  Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma.

Authors:  Satoshi Narahara; Takehisa Watanabe; Katsuya Nagaoka; Nahoko Fujimoto; Yoki Furuta; Kentaro Tanaka; Takayuki Tokunaga; Takeshi Kawasaki; Yoko Yoshimaru; Hiroko Setoyama; Kentaro Oniki; Junji Saruwatari; Masakuni Tateyama; Hideaki Naoe; Motohiko Tanaka; Yasuhito Tanaka; Yutaka Sasaki
Journal:  Hepatol Commun       Date:  2021-11-27

4.  Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation.

Authors:  Amanda G Vang; Chaitali Basole; Hongli Dong; Rebecca K Nguyen; William Housley; Linda Guernsey; Alexander J Adami; Roger S Thrall; Robert B Clark; Paul M Epstein; Stefan Brocke
Journal:  Front Pharmacol       Date:  2016-08-23       Impact factor: 5.810

5.  The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism.

Authors:  Xianming Wang; Xin Zhang; Fei Liu; Minghai Wang; Shiyong Qin
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 6.  The Role of PDE8 in T Cell Recruitment and Function in Inflammation.

Authors:  Paul M Epstein; Chaitali Basole; Stefan Brocke
Journal:  Front Cell Dev Biol       Date:  2021-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.